Table 4.
Details of 9 patients treated with ipsilateral radiation who developed recurrent nodal disease in the contralateral neck
| Patient | Smoker | HPV-associated cancer | Staging included PET | T-category | N-category | Size of largest node (cm) | Concurrent drug with radiation | Time to recurrence (from end of radiation) in contralateral neck | Other site(s) of recurrence | Status from time of recurrence |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Never | Unknown | No | 1 | 0 | None | 6 mo | None | Alive, 106 mo | |
| 2 | Former | Yes | No | 2 | 2b | 3.0 | None | 5 mo | Primary and ipsilateral neck | Dead, 65 mo |
| 3 | Never | Yes | Yes | 1 | 1 | 2.0 | None | 3 mo | None | Alive, 90 mo |
| 4 | Never | Yes | Yes | 2 | 2b | 1.7 | Cetuximab | 6 mo | None | Alive, 96 mo |
| 5 | Current | Yes | Yes | 1 | 2b | 3.6 | Cetuximab | 55 mo | Primary | Alive, 46 mo |
| 6 | Never | Yes | No | 2 | 1 | 1.7 | None | 47 mo | None | Alive, 45 mo |
| 7 | Never | Unknown | No | 1 | 2b | 3.0 | Cisplatin | 46 mo | None | Alive, 0 mo |
| 8 | Former | Yes | Yes | 2 | 2b | 2.8 | Cetuximab | 3 mo | Primary | Dead, 34 mo |
| 9 | Never | Yes | Yes | 2 | 2b | 2.1 | Cetuximab | 13 mo | None | Alive, 30 mo |
Abbreviations: HPV = human papillomavirus; PET = positron emission tomography.